Endorsed NICE Technology Appraisals 2007/2008

Topics:

Date published: 28 February 2008

Endorsed NICE Technology Appraisals 2007/2008

The following NICE Technology Appraisals were endorsed by DoH during 2007-08

Documents

National Institute for Health and Clinical Excellence (NICE) Technology Appraisal TA102 - Parent-training / education programmes in the management of children with conduct disorders - HSC (SQSD) (NICE) 12/2008Adobe PDF (313.75 KB)
National Institute for Health and Clinical Excellence (NICE) Technology Appraisal TA106 - Peginterferon alfa and ribavirin for the treatment of mild chronic hepatitis C - HSC (SQSD) (NICE) 27/2007Adobe PDF (484.46 KB)
National Institute for Health and Clinical Excellence (NICE) Technology Appraisal TA114 - Drug Misuse - Methadone and Buprenorphine - HSC (SQSD) (NICE) 14/2007Adobe PDF (483.73 KB)
National Institute for Health and Clinical Excellence (NICE) Technology Appraisal TA115 - Drug Misuse - Naltrexone - HSC (SQSD) (NICE) 15/2007Adobe PDF (483.45 KB)
National Institute for Health and Clinical Excellence (NICE) Technology Appraisal TA116 - Breast Cancer - Gemcitabine - HSC (SQSD) (NICE) 29/2007Adobe PDF (480.45 KB)
National Institute for Health and Clinical Excellence (NICE) Technology Appraisal TA117 - Cinacalcet for the treatment of secondary hyperparathyroidism in patients with end-stage renal disease on maintenance dialysis - HSC (SQSD) (NICE) 31/2007Adobe PDF (494.1 KB)
National Institute for Health and Clinical Excellence (NICE) Technology Appraisal TA118 - Colorectal Caner - Bevacizumab & Cetuximab - HSC (SQSD) (NICE) 16/2007Adobe PDF (486.23 KB)
National Institute for Health and Clinical Excellence (NICE) Technology Appraisal TA119 - Fludarabine monotherapy for the first-line treatment of Chronic Lymphocytic Leukaemia (CLL) - HSC (SQSD) (NICE) 30/2007Adobe PDF (482.1 KB)
National Institute for Health and Clinical Excellence (NICE) Technology Appraisal TA120 - Heart Failure - Cardiac Resynchronisation - HSC (SQSD) (NICE) 08/2008Adobe PDF (307.71 KB)
National Institute for Health and Clinical Excellence (NICE) Technology Appraisal TA121 - Carmustine implants and temolozomide for glioma - HSC (SQSD) (NICE) 09/2008Adobe PDF (315.21 KB)
National Institute for Health and Clinical Excellence (NICE) Technology Appraisal TA127 - Multiple Sclerosis - Natalizumab - HSC (SQSD) (NICE) 04/2008Adobe PDF (315.94 KB)
National Institute for Health and Clinical Excellence (NICE) Technology Appraisal TA128 - Stapled haemorroidopexy for the treatment of haemorrhoids - HSC (SQSD) (NICE) 14/2008Adobe PDF (307.83 KB)
National Institute for Health and Clinical Excellence (NICE) Technology Appraisal TA129 - Multiple myeloma - bortezomib monotherapy - HSC (SQSD) (NICE) 10/2008Adobe PDF (314.08 KB)
National Institute for Health and Clinical Excellence (NICE) Technology Appraisal TA135 - Pemetrexed disodium for the treatment of malignant pleural mesothelioma - HSC (SQSD) (NICE) 11/2008Adobe PDF (308.46 KB)